Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4754810
Max Phase: Preclinical
Molecular Formula: C35H43N3O2
Molecular Weight: 537.75
Molecule Type: Unknown
Associated Items:
ID: ALA4754810
Max Phase: Preclinical
Molecular Formula: C35H43N3O2
Molecular Weight: 537.75
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC/C(=C(/c1ccc(NC(=O)C2CCN(C)CC2)cc1)c1ccc(OCCN2CCCC2)cc1)c1ccccc1
Standard InChI: InChI=1S/C35H43N3O2/c1-3-33(27-9-5-4-6-10-27)34(29-13-17-32(18-14-29)40-26-25-38-21-7-8-22-38)28-11-15-31(16-12-28)36-35(39)30-19-23-37(2)24-20-30/h4-6,9-18,30H,3,7-8,19-26H2,1-2H3,(H,36,39)/b34-33+
Standard InChI Key: QZYZQDMZNKXJSA-JEIPZWNWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 537.75 | Molecular Weight (Monoisotopic): 537.3355 | AlogP: 6.81 | #Rotatable Bonds: 10 |
Polar Surface Area: 44.81 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.95 | CX Basic pKa: 9.23 | CX LogP: 6.48 | CX LogD: 3.41 |
Aromatic Rings: 3 | Heavy Atoms: 40 | QED Weighted: 0.29 | Np Likeness Score: -1.03 |
1. Cooper L,Schafer A,Li Y,Cheng H,Medegan Fagla B,Shen Z,Nowar R,Dye K,Anantpadma M,Davey RA,Thatcher GRJ,Rong L,Xiong R. (2020) Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus Inhibitors., 63 (19.0): [PMID:32886512] [10.1021/acs.jmedchem.0c01001] |
Source(1):